Literature DB >> 27568

Enrichment of in vitro and in vivo immunologic activity of purified fractions of calf thymic hormone.

Y Yakir, A I Kook, N Trainin.   

Abstract

Thymus humoral factor (THF), a thymus hormone which participates in the processes leading to acquisition of immunocompetence of lymphoid cells has been isolated in our laboratory by a stepwise gel filtration through various Sephadex columns. THF so isolated appears to be a polypeptide of 3,000 mol wt which contains approximately 30 amino acid residues. Here we have tested the biological activity of THF fractions of successive degrees of purity upon lymphoid cells from both intact and neonatally thymectomized mice. The lymphoid cell populations were treated with the various THF fractions by in vitro incubation for a short time and by repeated injection in vivo. The treated cells evidenced increased ability to react in the graft-versus-host assay in vivo and in mixed lymphocyte cultures in vitro concomitantly with the rise of intracellular cAMP. On the other hand no activity whatsoever was shown by any of the control materials tested. These bioassays permitted isolation of fractions progressively more active than the original crude dialyzate of thymus extract tested. Thus the active peptide component of THF eluted from DEAE Sephadex A-25 column was estimated to be 2 X 10(4)-fold more active than the crude dialyzate of thymus extract which served as a starting material.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27568      PMCID: PMC2184926          DOI: 10.1084/jem.148.1.71

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Increased mitogenic reactivity of normal spleen cells to T lectins induced by thymus humoral factor (THF).

Authors:  V Rotter; N Trainin
Journal:  Cell Immunol       Date:  1975-04       Impact factor: 4.868

2.  A study of the graft-versus-host reaction in transplantation to embryos, F1 hybrids, and irradiated animals.

Authors:  M SIMONSEN; J ENGELBRETH-HOLM; E JENSEN; H POULSEN
Journal:  Ann N Y Acad Sci       Date:  1958-10-07       Impact factor: 5.691

3.  Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human.

Authors:  J F Bach; M Dardenne; J M Pleau; M A Bach
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

4.  The control exerted by thymic hormone (THF) on cellular cAMP levels and immune reactivity of spleen cells in the MLC assay.

Authors:  A I Kook; N Trinin
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

5.  Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor.

Authors:  T Umiel; N Trainin
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

6.  Intracellular events involved in the induction of immune competence in lymphoid cells by a thymus humoral factor.

Authors:  A I Kook; N Trainin
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

7.  Chemical synthesis of a peptide fragment of thymopoietin II that induces selective T cell differentiation.

Authors:  D H Schlesinger; G Goldstein; M P Scheid; E A Boyse
Journal:  Cell       Date:  1975-08       Impact factor: 41.582

8.  Immune deficiency of T system with possible T cell regulatory activity defect.

Authors:  Z T Handzel; S Levin; A Ashkenazi; T Hahn; Y Altman; B Czernobilsky; B Shechter; N Trainin
Journal:  Isr J Med Sci       Date:  1977-04

9.  Severe disseminated adenovirus infection successfully treated with a thymic humoral factor, THF.

Authors:  I Varsano; T M Schonfeld; Y Matoth; B Shohat; T Englander; V Rotter; N Trainin
Journal:  Acta Paediatr Scand       Date:  1977-05

10.  Reconstitution of T cell function in patients with subacute sclerosing panencephalitis treated with thymus humoral factor.

Authors:  I Varsano; Y Danon; L Jaber; E Livni; B Shohat; Y Yakir; A Shneyour; N Trainin
Journal:  Isr J Med Sci       Date:  1976-10
View more
  3 in total

1.  Evaluation of the morphological and functional characteristics of murine thymic non-lymphoid cells grown in vitro.

Authors:  C M Harper; J G Sharp
Journal:  J Anat       Date:  1981-06       Impact factor: 2.610

2.  Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors.

Authors:  M Lenfant; L Millerioux; I Blazsek; N Duchange
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

3.  Enhancement of natural killer cell activity in mice by treatment with a thymic factor.

Authors:  F Bistoni; M Baccarini; P Puccetti; P Marconi; E Garaci
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.